Pond, Gregory R <br/><br/>
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.  [electronic resource] 

 -  BJU international  May 2014 
 - E137-43 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-410X 
<br/><br/><label>Standard No.: </label>10.1111/bju.12564  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Transitional Cell--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Liver Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Nomograms<br/>Prognosis<br/>Urologic Neoplasms--drug therapy